1. Home
  2. TECX vs MVIS Comparison

TECX vs MVIS Comparison

Compare TECX & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • MVIS
  • Stock Information
  • Founded
  • TECX 2019
  • MVIS 1993
  • Country
  • TECX United States
  • MVIS United States
  • Employees
  • TECX N/A
  • MVIS N/A
  • Industry
  • TECX
  • MVIS Industrial Machinery/Components
  • Sector
  • TECX
  • MVIS Technology
  • Exchange
  • TECX Nasdaq
  • MVIS Nasdaq
  • Market Cap
  • TECX 387.1M
  • MVIS 403.3M
  • IPO Year
  • TECX 2018
  • MVIS 1996
  • Fundamental
  • Price
  • TECX $15.34
  • MVIS $1.37
  • Analyst Decision
  • TECX Buy
  • MVIS Strong Buy
  • Analyst Count
  • TECX 6
  • MVIS 3
  • Target Price
  • TECX $79.17
  • MVIS $2.50
  • AVG Volume (30 Days)
  • TECX 480.8K
  • MVIS 6.1M
  • Earning Date
  • TECX 11-06-2025
  • MVIS 11-06-2025
  • Dividend Yield
  • TECX N/A
  • MVIS N/A
  • EPS Growth
  • TECX N/A
  • MVIS N/A
  • EPS
  • TECX N/A
  • MVIS N/A
  • Revenue
  • TECX N/A
  • MVIS $2,584,000.00
  • Revenue This Year
  • TECX N/A
  • MVIS N/A
  • Revenue Next Year
  • TECX N/A
  • MVIS $857.46
  • P/E Ratio
  • TECX N/A
  • MVIS N/A
  • Revenue Growth
  • TECX N/A
  • MVIS N/A
  • 52 Week Low
  • TECX $13.70
  • MVIS $0.80
  • 52 Week High
  • TECX $61.07
  • MVIS $1.95
  • Technical
  • Relative Strength Index (RSI)
  • TECX 36.96
  • MVIS 72.94
  • Support Level
  • TECX $14.62
  • MVIS $1.23
  • Resistance Level
  • TECX $15.47
  • MVIS $1.54
  • Average True Range (ATR)
  • TECX 0.91
  • MVIS 0.09
  • MACD
  • TECX 0.20
  • MVIS 0.02
  • Stochastic Oscillator
  • TECX 23.04
  • MVIS 74.24

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.

Share on Social Networks: